What is CuePath Innovation?
CuePath Innovation operates at the intersection of clinical research and digital health, providing specialized monitoring tools designed to mitigate the risks associated with self-reported data in drug trials. The company's flagship offering, CueStickers, utilizes advanced sensor technology integrated into blister packs to facilitate real-time data collection. This innovation addresses a critical pain point in clinical research—specifically within addiction and pain management studies—by replacing subjective patient reporting with objective, verifiable data. By ensuring seamless integration with existing clinical trial management software, CuePath Innovation enhances participant retention and data integrity, effectively setting a new standard for compliance and safety in complex pharmaceutical development environments.
How much funding has CuePath Innovation raised?
CuePath Innovation has raised a total of $1.8M across 1 funding round:
Angel/Seed
$1.8M
Angel/Seed (2017): $1.8M with participation from E Fund Management
Key Investors in CuePath Innovation
E Fund Management
A prominent investment firm based in Guangzhou, China, specializing in robust research, prudent risk management, and large-scale asset management solutions.
What's next for CuePath Innovation?
With the infusion of this recent capital, CuePath Innovation is poised to deepen its market penetration and refine its product suite to meet the rigorous demands of large-scale clinical trials. The company's strategic roadmap likely involves expanding its software interoperability and scaling its manufacturing capabilities to support a broader range of therapeutic areas. As the industry shifts toward decentralized clinical trials, CuePath's ability to provide high-fidelity, real-time adherence data will be instrumental in securing long-term partnerships with global pharmaceutical entities. The focus remains on driving operational excellence and maintaining a competitive edge in the rapidly evolving landscape of digital health monitoring.
See full CuePath Innovation company page